Literature DB >> 15273151

Susceptibility of Chlamydia trachomatis to excipients commonly used in topical microbicide formulations.

M F Lampe1, L C Rohan, M C Skinner, W E Stamm.   

Abstract

Commonly used "inactive" pharmaceutical excipients were tested in a previously developed minimum cidal concentration assay to assess their ability to kill Chlamydia trachomatis topically. Sixteen excipients were evaluated in these studies under various conditions. A range of activities was found among the excipients that could be tested in our assay system.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15273151      PMCID： PMC478553          DOI： 10.1128/AAC.48.8.3200-3202.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  11 in total

1.  Design of a "microbicide" for prevention of sexually transmitted diseases using "inactive" pharmaceutical excipients.

Authors:  A R Neurath; N Strick; Y Y Li; K Lin; S Jiang
Journal:  Biologicals       Date:  1999-03       Impact factor: 1.856

2.  Immunization against scrub typhus. II. Preparation of lyophilized living vaccine.

Authors:  E B JACKSON; J E SMADEL
Journal:  Am J Hyg       Date:  1951-05

3.  In vitro microbicidal activities of cecropin peptides D2A21 and D4E1 and gel formulations containing 0.1 to 2% D2A21 against Chlamydia trachomatis.

Authors:  L M Ballweber; J E Jaynes; W E Stamm; M F Lampe
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

4.  Killing of Chlamydia trachomatis by novel antimicrobial lipids adapted from compounds in human breast milk.

Authors:  M F Lampe; L M Ballweber; C E Isaacs; D L Patton; W E Stamm
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

5.  Purification on renografin density gradients of Chlamydia trachomatis grown in the yolk sac of eggs.

Authors:  L Howard; N S Orenstein; N W King
Journal:  Appl Microbiol       Date:  1974-01

6.  Susceptibility of human and murine Chlamydia trachomatis serovars to granulocyte- and epithelium-derived antimicrobial peptides.

Authors:  C Chong-Cerrillo; M E Selsted; E M Peterson; L M de la Maza
Journal:  J Pept Res       Date:  2003-05

7.  Bile salts: natural detergents for the prevention of sexually transmitted diseases.

Authors:  B C Herold; R Kirkpatrick; D Marcellino; A Travelstead; V Pilipenko; H Krasa; J Bremer; L J Dong; M D Cooper
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

8.  In vitro inactivation of Chlamydia trachomatis and of a panel of DNA (HSV-2, CMV, adenovirus, BK virus) and RNA (RSV, enterovirus) viruses by the spermicide benzalkonium chloride.

Authors:  L Bélec; C Tevi-Benissan; A Bianchi; S Cotigny; M Beumont-Mauviel; A Si-Mohamed; J E Malkin
Journal:  J Antimicrob Chemother       Date:  2000-11       Impact factor: 5.790

9.  Simplified microtiter cell culture method for rapid immunotyping of Chlamydia trachomatis.

Authors:  R J Suchland; W E Stamm
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

10.  Susceptibility of Chlamydia trachomatis to chlorhexidine gluconate gel.

Authors:  M F Lampe; L M Ballweber; W E Stamm
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191
View more
  2 in total

1.  Susceptibility of Chlamydia trachomatis to the excipient hydroxyethyl cellulose: pH and concentration dependence of antimicrobial activity.

Authors:  Ali A Abdul Sater; David M Ojcius; Matthew P Meyer
Journal:  Antimicrob Agents Chemother       Date:  2008-04-14       Impact factor: 5.191

2.  Coxiella burnetii-Infected NK Cells Release Infectious Bacteria by Degranulation.

Authors:  Svea Matthiesen; Luca Zaeck; Kati Franzke; Rico Jahnke; Charlie Fricke; Michael Mauermeir; Stefan Finke; Anja Lührmann; Michael R Knittler
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.